Skip to main content
FDA Updates
Omacetaxine Mepesuccinate: A Novel mRNA Translation Inhibitor for Drug-Resistant Chronic Myelogenous Leukemia
Jacqueline L. Olin, MS, PharmD, BCPS, Sabrina W. Cole, PharmD, BCPS, Amie J. Dirks-Naylor, PhD
Read More
FDA Updates
Recent Cancer Drugs Approved by the FDA
Read More
Original Research
The Impact of Angiotensin II Receptor Blocker Use in Patients with Prostate Cancer
Lisa Cerutti, PharmD, Jacob K. Kettle, PharmD, BCOP, Dennis W. Grauer, MS, PhD
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform
Read More
Supplements
Introduction to the Resident Reporter Program: Part 2
Patrick J. Medina, PharmD, BCOP, FHOPA
Read More
Highlights from Key Meetings in Hematology and Oncology
Brian Dinh, PharmD, Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Practical Issues in Pharmacy Management
Financial Savings from On-Site Dispensing of Oral Chemotherapies
Adam Kramer, PharmD, Colleen Powell, CPhT
Read More
FDA Updates
FLAG-IDA Regimen-Induced Thrombotic Microangiopathy: A Case Report
Juan Montoro, MD, Montserrat Gomez, MD, Mar Tomo, MD PhD, Teresa Torrecillas, PhD
Read More
Original Research
Quantification of Weight Changes Associated with New Diagnosis of Cancer in Pediatric Patients
Misty M. Miller, PharmD, BCPS, Teresa V. Lewis, PharmD, BCPS, Ryan Webb, MPH, David A. Fields, PhD
Read More
Page 187 of 200
Results 1861 - 1870 of 1993